Friday, July 1, 2016

BRIEF-Citius Pharmaceuticals discontinues Suprenza to focus on core assets

* Citius Pharmaceuticals discontinues Suprenza to focus on

core assets

Source text for Eikon:

Further company coverage:

(Bengaluru Newsroom: +1-646-223-8780)

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)